Abatacept is a T-cell co-stimulatory inhibitor that inhibits T cell activation by specifically interfering with CD28 interaction with CD80/86.[132] Many evidence have supported the efficacy and safety of abatacept in treating RA[133,134,135] and it can be used as one of the bDMARD medications. Here, CD28 is linked to rheumatoid arthritis.